Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.3.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.3.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.3.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.3.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.5.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.5.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.5.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.5.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.5.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.5.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.5.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBDEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBDECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBDECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBDEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBDEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBDENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBDENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EB.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
EB.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EB.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EB.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EB.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CN.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CN.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CN.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CN.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CN.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CN.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CN.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.77EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.77EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used